Mechanism of cell death caused by complex I defects in a rat dopaminergic cell line

Mathieu Marella1, Byoung Boo Seo, Akemi Matsuno-Yagi

  • 1Division of Biochemistry, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.

Insights

Mitochondrial complex I defects cause neurodegeneration. Yeast Ndi1 enzyme prevents cell death by reducing reactive oxygen species (ROS) and kinase activation, offering a potential therapeutic strategy for these disorders.

Area of Science:

  • Mitochondrial biochemistry
  • Neurobiology
  • Cell death pathways

Background:

  • Defects in mitochondrial NADH-quinone oxidoreductase (complex I) are implicated in neurodegenerative diseases.
  • The precise mechanisms driving cell death due to complex I deficiency are not fully understood.

Purpose of the Study:

  • To investigate the key events leading to cell death in complex I deficiency using a rat dopaminergic cell line (PC12).
  • To explore the protective potential of the yeast NADH-quinone oxidoreductase (Ndi1) enzyme against complex I dysfunction.

Main Methods:

  • Utilized the rotenone-insensitive yeast Ndi1 enzyme to rescue mammalian cells from complex I dysfunction.
  • Investigated cell death pathways, including kinase activation and mitochondrial proapoptotic factor release.
  • Assessed the role of reactive oxygen species (ROS) and caspase activation.

Main Results:

  • Complex I inhibition triggered kinase pathway activation and release of mitochondrial proapoptotic factors (apoptosis-inducing factor, endonuclease G).
  • A kinase inhibitor (AS601245) provided significant protection, while caspase 3 activation was not observed.
  • The yeast Ndi1 enzyme nearly completely prevented apoptotic cell death by maintaining high redox potential and reducing ROS generation.

Conclusions:

  • Reactive oxygen species (ROS) overproduction, driven by complex I inhibition, is a key mediator of kinase activation, proapoptotic factor release, and subsequent cell death.
  • The caspase-independent cell death pathway is involved.
  • The Ndi1 enzyme demonstrates significant therapeutic potential for neurodegenerative diseases linked to complex I defects by mitigating ROS production.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...